6-29670324-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_206809.4(MOG):c.636T>A(p.Phe212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000419 in 1,614,190 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. F212F) has been classified as Likely benign.
Frequency
Consequence
NM_206809.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MOG | NM_206809.4 | c.636T>A | p.Phe212Leu | missense_variant | 6/8 | ENST00000376917.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MOG | ENST00000376917.8 | c.636T>A | p.Phe212Leu | missense_variant | 6/8 | 1 | NM_206809.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00248 AC: 377AN: 152178Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000569 AC: 143AN: 251496Hom.: 0 AF XY: 0.000405 AC XY: 55AN XY: 135922
GnomAD4 exome AF: 0.000203 AC: 297AN: 1461894Hom.: 1 Cov.: 31 AF XY: 0.000160 AC XY: 116AN XY: 727248
GnomAD4 genome AF: 0.00250 AC: 380AN: 152296Hom.: 1 Cov.: 32 AF XY: 0.00244 AC XY: 182AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The MOG p.Phe212Leu variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs112913018) and LOVD 3.0. The variant was identified in control databases in 212 of 282896 chromosomes at a frequency of 0.0007494 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 198 of 24966 chromosomes (freq: 0.007931), Latino in 11 of 35440 chromosomes (freq: 0.00031), Other in 2 of 7228 chromosomes (freq: 0.000277) and European (non-Finnish) in 1 of 129198 chromosomes (freq: 0.000008), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or South Asian populations. The p.Phe212 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at